Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma

Journal of B.U.ON.

Volumn 18, Issue 4, 2013, Pages 982-988

  Bar Ad, V ^a   Wang, Z X ^a   Leiby, B ^b   Tuluc, M ^a  

^a Department of Radiation Oncology ^*  (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Anemia; Oropharyngeal carcinoma; Pi6 level; Smoking

Indexed keywords

CETUXIMAB; HEMOGLOBIN; PLATINUM; PROTEIN P16; TUMOR MARKER;

ADULT; AGED; ANEMIA; ARTICLE; CANCER PATIENT; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; LOCOREGIONAL DISEASE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; POSTOPERATIVE CARE; PROTEIN EXPRESSION; RADIATION DOSE; SMOKING; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; ANEMIA; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CHI-SQUARE DISTRIBUTION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RISK FACTORS; SMOKING; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84893038784     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Gillison M, D'Souza G, Westra W et al. Distinct risk factor profiles for human papillomavirustype 16-positive and human papillomavirus 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407-420. (Pubitemid 351480511)
2. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infectiomreview and meta-analysis. Int J Cancer 2007;121:1813-1820. (Pubitemid 47417302)
3. Fakhry C, Westra WH, Li S et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261-269. (Pubitemid 351480538)
4. Ang K, Harris J, Wheeler R et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
5. Licitra L, Perrone F, Bossi P et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006;24:5630-5636. (Pubitemid 46631302)
6. Lindquist D, Romanitan M, Hammarstedt L et al. Human papillomavirus is a favorable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 2007; 1:350-355. (Pubitemid 350186274)
7. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsmer J, Overgaard J. Effect of HPV-associated pl6INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009;27:1992-1998.
8. Weinberger PM, Yu Z, Haffty BG et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006;24:736-747. (Pubitemid 46622040)
9. Kumar B, Cordell KG, Lee JS et al. EGFR, pl6, HPV Titer, Bcl-xl, and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008;3128-3137.
10. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer:A systematic, quantitative review. Cancer 2001;91:2214-2221. (Pubitemid 32552805)
11. Ludwig H, Fritz E. Anemia in cancer patients. Semin Oncol 1998;25(Suppl) 7):2-6.
12. Grogan M, Thomas GM, Melamed I et al. The importance of maintaining high hemoglobin levels during radiation treatment of carcinoma of the cervix. Cancer 1999;86:1528-1536. (Pubitemid 29489787)
13. Obermair A, Handisurya A, Kaider A, Sevelda P, Kolbl H, Gitsch G. The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients. Cancer 1998;83:726-731. (Pubitemid 28387696)
14. Blitzer PH, Wang CC, Suit HD. Blood pressure and hemoglobin concentration.-Multivariate analysis of local control after irradiation for head and neck cancer. Int J Radiat Oncol Biol Phys 1984;10(Suppl 2):98.
15. Fazekas JT, Scott C, Marcial V et al. The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers:Based on RTOG trial #79-15. Int J Radiat Oncol Biol Phys 1989,17:1177-1181. (Pubitemid 20028633)
16. van Acht WJ, Hermans J, Boks DE et al. The prognostic value of hemoglobin and decrease in hemoglobin during radiotherapy in laryngeal carcinoma. Radiother Oncol 1992;23:229-235.
17. Fein DA, Lee WR, Hanlon AL et al. Pretreatment he-moglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottis larynx. J Clin Oncol 1995;13:2077-2083.
18. Tamawski R, Skladowski K, Maciejewski B. Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx. Int J Radiat Oncol Biol Phys 1997;38:1007-1011. (Pubitemid 27353680)
19. Brizel DM, Albers ME, Fisher SR et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798-1804. (Pubitemid 28277960)
20. Warde P, O'Sullivan B, Bristow RG et al. T1/T2 glottic cancer managed by external beam radiotherapy:The influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys 1998;41:347-353. (Pubitemid 28243546)
21. Lee WR, Berkey B, Marcial V et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinomaA secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 1998:42:1069 -1075.
22. Smeets SJ, Hesselink AT, Speel EJ et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007;121:2465-2472. (Pubitemid 350022416)
23. Reimers N, Kasper HU, Weissenborn SJ et al. Combined analysis of HPV-DNA, pl6 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007;120:1731-1738. (Pubitemid 46399359)
24. Brizel DM, Dodge RK, Clough RW et al. Oxygenation of head and neck cancer:Changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999;53:113-117.
25. Stadler P, Becker A, Feldmann HJ et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 1999;44:749-754. (Pubitemid 29284123)
26. Prosnitz RG, Yao B, Farrell CL, Clough R, Brizel DM. Pretreatment anemia is correlated with reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2005;61:1087-1895.
27. Dunst J, Sadler P, Becker A et al. Tumor volume and tumor hypoxia in head and neck cancers:The amount of the hypoxic volume is important. Strahlerther Oncol 2003;179:521-526. (Pubitemid 36966408)
28. Hong JH, Chen MS, Lin FJ, Tang SG. Prognostic assessment of tumor regression after external irradiation for cervical cancer. Int J Radiat Oncol Biol Phys 1992;22:913-917.
29. Dische S. Radiotherapy and anemia:the clinical experience. Radiother Oncol 1991;20(Suppl):35-40.
30. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression of advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-4515. (Pubitemid 26330463)
31. Overgaard J, Hansen HS, Jorgensen K et al. Primary radiotherapy of larynx and pharynx carcinoma:An analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys 1986;12:515-521. (Pubitemid 16081611)
32. Glaser CM, Millesi W, Komek GV et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 2001;50:705-715. (Pubitemid 32519598)
33. Henke M, Laszig R, Rube C et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:randomized, double-blind, placebo-controlled trial. Lancet 2003;362:1255-1260. (Pubitemid 37324251)
34. Machtay M, Pajak TF, Suntharalingam M et al. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancen:a randomized trial of the Radiation Oncology Group (RTOG 99-03). Int J Radiat Oncol Biol Phys 2007;69:1008-1017. (Pubitemid 47625834)